Sphere Medical Holding plc Notice of Interim Results (6236I)
September 01 2016 - 1:00AM
UK Regulatory
TIDMSPHR
RNS Number : 6236I
Sphere Medical Holding plc
01 September 2016
1 September 2016
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Notice of Interim Results
Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of
innovative monitoring and diagnostic devices for the critical care
setting, will announce its interim results for the six months ended
30 June 2016 on Thursday 22 September 2016.
Dr. Wolfgang Rencken, Chief Executive Officer and Richard
Wright, Chief Financial Officer, will host a presentation and
conference call for analysts at 11:00 BST on the day of the results
at 85 Gresham Street, London, EC2R 7HE.
- Ends -
For further information, please contact:
Sphere Medical Holding plc Tel: +44 (0)1223 875 222
Dr Wolfgang Rencken, Chief Executive
Officer
Richard Wright, Chief Financial
Officer
Panmure Gordon Tel: +44 (0) 20 7886 2500
Freddy Crossley (Corporate
Finance)
Duncan Monteith (Corporate
Finance)
Tom Salvesen (Corporate Broking)
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott spheremedical@consilium-comms.com
Chris Gardner
Ivar Milligan
Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device
company. Its Proxima(TM) platform measures blood gases,
electrolytes and metabolites at the patient's bedside and aims to
improve patient care and reduce health system costs. The device is
currently sold directly to the critical care market via Sphere
Medical's sales force in the UK, Germany, The Netherlands and
Belgium. For further information, please visit
www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORLLFFDTLILVIR
(END) Dow Jones Newswires
September 01, 2016 02:00 ET (06:00 GMT)
Sphere Medical (LSE:SPHR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Sphere Medical (LSE:SPHR)
Historical Stock Chart
From Jan 2024 to Jan 2025